A tsunami of glaucoma is sweeping toward the U.S. healthcare system, according to Cynthia Mattox, MD. For many ophthalmologists, coping with the increased demand will mean teaming up with other eye-care professionals.
Glaucoma progression occurs slowly in the vast majority of patients, and most patients with glaucoma will not go blind from the disease. However, it is important to get early diagnosis, treatment when indicated, and develop a disease surveillance protocol.
Microinvasive glaucoma surgery devices already have transformed the management of glaucoma and will have a bigger impact in the future considering the options in the investigational pipeline and the opportunities they present.
Ophthalmologists need to prepare their practices for the Value-Based Payment (VBP) program for Medicare services. VBP is a strategy to promote quality and value of health care services, with providers being paid based on value-of-care-delivered rather than volume. Regardless of the perspectives, the fact remains that reimbursement can increase or decrease substantially with the VBP program.
Glaucoma is a common complication of uveitis, occurring in about 20% of affected eyes and arising through several different mechanisms.
Here are seven common mistakes clinicians make in evaluating and managing elevated IOP in eyes with uveitis.